{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T02:58:48Z","timestamp":1789181928536,"version":"build-2803163510"},"reference-count":48,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["92059110\/81872808"],"award-info":[{"award-number":["92059110\/81872808"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["2018SHZDZX01"],"award-info":[{"award-number":["2018SHZDZX01"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012247","name":"Program of Shanghai Academic Research Leader","doi-asserted-by":"publisher","award":["18XD1400500"],"award-info":[{"award-number":["18XD1400500"]}],"id":[{"id":"10.13039\/501100012247","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.apsb.2022.05.027","type":"journal-article","created":{"date-parts":[[2022,5,29]],"date-time":"2022-05-29T09:35:51Z","timestamp":1653816951000},"page":"298-314","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["A neutrophil-biomimic platform for eradicating metastatic breast cancer stem-like cells by redox microenvironment modulation and hypoxia-triggered differentiation therapy"],"prefix":"10.1016","volume":"13","author":[{"given":"Yongchao","family":"Chu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boyu","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiwen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peixin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenhao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5223-2725","authenticated-orcid":false,"given":"Chen","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2022.05.027_bib1","first-page":"438","article-title":"Breast cancer statistics","volume":"69","author":"DeSantis","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.apsb.2022.05.027_bib2","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nrclinonc.2016.66","article-title":"Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease","volume":"13","author":"Bianchini","year":"2016","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.apsb.2022.05.027_bib3","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1080\/15384047.2018.1456599","article-title":"Breast cancer lung metastasis: molecular biology and therapeutic implications","volume":"19","author":"Jin","year":"2018","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.apsb.2022.05.027_bib4","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1007\/s11427-020-1714-8","article-title":"Triple-negative breast cancer: new treatment strategies in the era of precision medicine","volume":"64","author":"Wu","year":"2021","journal-title":"Sci China Life Sci"},{"key":"10.1016\/j.apsb.2022.05.027_bib5","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/nrclinonc.2015.123","article-title":"Precision medicine for metastatic breast cancer\u2014limitations and solutions","volume":"12","author":"Arnedos","year":"2015","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.apsb.2022.05.027_bib6","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1016\/j.addr.2013.08.004","article-title":"Nanopreparations to overcome multidrug resistance in cancer","volume":"65","author":"Patel","year":"2013","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.apsb.2022.05.027_bib7","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.apsb.2019.05.006","article-title":"Targeting peptide-decorated biomimetic lipoproteins improve deep penetration and cancer cells accessibility in solid tumor","volume":"10","author":"Tan","year":"2020","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2022.05.027_bib8","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1126\/scitranslmed.aac6522","article-title":"Predicting therapeutic nanomedicine efficacy using a companion magnetic resonance imaging nanoparticle","volume":"7","author":"Miller","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.apsb.2022.05.027_bib9","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/nrc3180","article-title":"Treating metastatic cancer with nanotechnology","volume":"12","author":"Schroeder","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.apsb.2022.05.027_bib10","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1470-2045(00)00006-1","article-title":"The role of hypoxia-activated prodrugs in cancer therapy","volume":"1","author":"Denny","year":"2000","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.apsb.2022.05.027_bib11","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nri3789","article-title":"Immune cell promotion of metastasis","volume":"15","author":"Kitamura","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.apsb.2022.05.027_bib12","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.it.2015.11.008","article-title":"Neutrophils in the tumor microenvironment","volume":"37","author":"Powell","year":"2016","journal-title":"Trends Immunol"},{"key":"10.1016\/j.apsb.2022.05.027_bib13","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/s41586-019-0915-y","article-title":"Neutrophils escort circulating tumour cells to enable cell cycle progression","volume":"566","author":"Szczerba","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2022.05.027_bib14","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/onc.2016.217","article-title":"TNFalpha-activated mesenchymal stromal cells promote breast cancer metastasis by recruiting CXCR2(+) neutrophils","volume":"36","author":"Yu","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.apsb.2022.05.027_bib15","first-page":"3060","article-title":"Nanomedicine for acute respiratory distress syndrome: the latest application, targeting strategy, and rational design","volume":"11","author":"Qiao","year":"2021","journal-title":"Acta Pharm"},{"key":"10.1016\/j.apsb.2022.05.027_bib16","doi-asserted-by":"crossref","first-page":"1701021","DOI":"10.1002\/adma.201701021","article-title":"Photosensitization priming of tumor microenvironments improves delivery of nanotherapeutics via neutrophil infiltration","volume":"29","author":"Chu","year":"2017","journal-title":"Adv Mater"},{"key":"10.1016\/j.apsb.2022.05.027_bib17","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nrclinonc.2017.44","article-title":"EMT, CSCs, and drug resistance: the mechanistic link and clinical implications","volume":"14","author":"Shibue","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.apsb.2022.05.027_bib18","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ccr.2012.03.003","article-title":"Cancer stem cells: impact, heterogeneity, and uncertainty","volume":"21","author":"Magee","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.apsb.2022.05.027_bib19","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.apsb.2020.09.016","article-title":"Recent advances in drug delivery systems for targeting cancer stem cells","volume":"11","author":"Duan","year":"2021","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2022.05.027_bib20","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ctrv.2018.07.004","article-title":"Cancer stem cell in breast\u00a0cancer therapeutic resistance","volume":"69","author":"Bai","year":"2018","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.apsb.2022.05.027_bib21","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/s41556-018-0256-3","article-title":"Chemotherapy elicits pro-metastatic extracellular vesicles in breast cancer models","volume":"21","author":"Keklikoglou","year":"2019","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.apsb.2022.05.027_bib22","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.cell.2009.08.017","article-title":"Heterogeneity in cancer: cancer stem cells versus clonal evolution","volume":"138","author":"Shackleton","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.apsb.2022.05.027_bib23","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan0026","article-title":"Neoadjuvant chemotherapy induces breast cancer metastasis through a TMEM-mediated mechanism","volume":"9","author":"Karagiannis","year":"2017","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.apsb.2022.05.027_bib24","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/nature05349","article-title":"Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells","volume":"444","author":"Piccirillo","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2022.05.027_bib25","doi-asserted-by":"crossref","first-page":"5857","DOI":"10.1158\/0008-5472.CAN-15-2745","article-title":"RANK signaling blockade reduces breast cancer recurrence by inducing tumor cell differentiation","volume":"76","author":"Yoldi","year":"2016","journal-title":"Cancer Res"},{"key":"10.1016\/j.apsb.2022.05.027_bib26","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nature22081","article-title":"Visualization and targeting of LGR5(+) human colon cancer stem cells","volume":"545","author":"Shimokawa","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2022.05.027_bib27","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.4161\/cc.8.20.9761","article-title":"Retinoid signaling regulates breast cancer stem cell differentiation","volume":"8","author":"Ginestier","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.apsb.2022.05.027_bib28","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jconrel.2010.10.019","article-title":"All-trans retinoic acid stealth liposomes prevent the relapse of breast cancer arising from the cancer stem cells","volume":"149","author":"Li","year":"2011","journal-title":"J Contr Release"},{"key":"10.1016\/j.apsb.2022.05.027_bib29","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.cell.2011.07.026","article-title":"Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells","volume":"146","author":"Gupta","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.apsb.2022.05.027_bib30","doi-asserted-by":"crossref","first-page":"2102256","DOI":"10.1002\/advs.202102256","article-title":"A versatile theranostic platform for colorectal cancer peritoneal metastases: real-time tumor-tracking and photothermal-enhanced chemotherapy","volume":"8","author":"Sun","year":"2021","journal-title":"Adv Sci"},{"key":"10.1016\/j.apsb.2022.05.027_bib31","doi-asserted-by":"crossref","first-page":"31743","DOI":"10.1021\/acsami.9b12129","article-title":"Rational design of nanoparticles to overcome poor tumor penetration and hypoxia-induced chemotherapy resistance: combination of optimizing size and self-inducing high level of reactive oxygen species","volume":"11","author":"Deng","year":"2019","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.apsb.2022.05.027_bib32","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1039\/C8BM01042K","article-title":"Hypoxia- and singlet oxygen-responsive chemo-photodynamic micelles featured with glutathione depletion and aldehyde production","volume":"7","author":"Deng","year":"2018","journal-title":"Biomater Sci"},{"key":"10.1016\/j.apsb.2022.05.027_bib33","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1021\/acs.nanolett.9b03753","article-title":"Pseudoneutrophil cytokine sponges disrupt myeloid expansion and tumor trafficking to improve cancer immunotherapy","volume":"20","author":"Li","year":"2020","journal-title":"Nano Lett"},{"key":"10.1016\/j.apsb.2022.05.027_bib34","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1021\/acsnano.6b06477","article-title":"Nanoparticles coated with neutrophil membranes can effectively treat cancer metastasis","volume":"11","author":"Kang","year":"2017","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2022.05.027_bib35","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/nnano.2017.54","article-title":"Neutrophil-mediated anticancer drug delivery for suppression of postoperative malignant glioma recurrence","volume":"12","author":"Xue","year":"2017","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.apsb.2022.05.027_bib36","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/j.apsb.2020.01.004","article-title":"Recent progress of hypoxia-modulated multifunctional nanomedicines to enhance photodynamic therapy: opportunities, challenges, and future development","volume":"10","author":"Sun","year":"2020","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2022.05.027_bib37","first-page":"509","article-title":"Clinical evaluation of nitroimidazoles as modifiers of hypoxia in solid tumors","volume":"6","author":"Overgaard","year":"1994","journal-title":"Oncol Res"},{"key":"10.1016\/j.apsb.2022.05.027_bib38","doi-asserted-by":"crossref","first-page":"14715","DOI":"10.1021\/acsnano.0c00764","article-title":"Electron-accepting micelles deplete reduced nicotinamide adenine dinucleotide phosphate and impair two antioxidant cascades for ferroptosis-induced tumor eradication","volume":"14","author":"Guo","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2022.05.027_bib39","doi-asserted-by":"crossref","first-page":"22544","DOI":"10.1002\/anie.202004008","article-title":"Hypoxia-induced pro-protein therapy assisted by a self-catalyzed nanozymogen","volume":"59","author":"Li","year":"2020","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.apsb.2022.05.027_bib40","doi-asserted-by":"crossref","first-page":"1802891","DOI":"10.1002\/smll.201802891","article-title":"Biophysical phenotyping and modulation of ALDH+ inflammatory breast cancer stem-like cells","volume":"15","author":"Chen","year":"2019","journal-title":"Small"},{"key":"10.1016\/j.apsb.2022.05.027_bib41","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.biomaterials.2014.10.018","article-title":"Co-delivery of all-trans-retinoic acid and doxorubicin for cancer therapy with synergistic inhibition of cancer stem cells","volume":"37","author":"Sun","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.apsb.2022.05.027_bib42","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nm.3839","article-title":"Active Pin 1 is a key target of all-trans retinoic acid in acute promyelocytic leukemia and breast cancer","volume":"21","author":"Wei","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.apsb.2022.05.027_bib43","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/emmm.201302909","article-title":"Prolyl-isomerase Pin 1 controls normal and cancer stem cells of the breast","volume":"6","author":"Rustighi","year":"2014","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.apsb.2022.05.027_bib44","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.jconrel.2021.07.048","article-title":"Selective transferrin coating as a facile strategy to fabricate BBB-permeable and targeted vesicles for potent RNAi therapy of brain metastatic breast cancer in\u00a0vivo","volume":"337","author":"Wei","year":"2021","journal-title":"J Contr Release"},{"key":"10.1016\/j.apsb.2022.05.027_bib45","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jconrel.2020.10.023","article-title":"PSMA-targeted nanoparticles for specific penetration of blood\u2012brain tumor barrier and combined therapy of brain metastases","volume":"329","author":"Ni","year":"2021","journal-title":"J Contr Release"},{"key":"10.1016\/j.apsb.2022.05.027_bib46","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.apsb.2020.10.015","article-title":"Escape from abluminal LRP1-mediated clearance for boosted nanoparticle brain delivery and brain metastasis treatment","volume":"11","author":"Naveed","year":"2021","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2022.05.027_bib47","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jconrel.2019.04.031","article-title":"LRP1-upregulated nanoparticles for efficiently conquering the blood-brain barrier and targetedly suppressing multifocal and infiltrative brain metastases","volume":"303","author":"Guo","year":"2019","journal-title":"J Contr Release"},{"key":"10.1016\/j.apsb.2022.05.027_bib48","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1016\/j.apsb.2020.11.023","article-title":"Evolution of blood\u2013brain barrier in brain diseases and related systemic nanoscale brain-targeting drug delivery strategies","volume":"11","author":"Han","year":"2021","journal-title":"Acta Pharm Sin B"}],"updated-by":[{"DOI":"10.1016\/j.apsb.2026.06.039","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000}},{"DOI":"10.1016\/j.apsb.2026.06.039","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000}}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383522002490?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383522002490?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T12:17:22Z","timestamp":1762604242000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383522002490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S2211383522002490"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2022.05.027","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A neutrophil-biomimic platform for eradicating metastatic breast cancer stem-like cells by redox microenvironment modulation and hypoxia-triggered differentiation therapy","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2022.05.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}